Cutaneous Toxicities of MEK Inhibitor Use in Children: A Comparison of Binimetinib and Selumetinib
Sign Up to like & getrecommendations! Published in 2024 at "Pediatric Dermatology"
DOI: 10.1111/pde.15792
Abstract: Binimetinib and selumetinib are two mitogen‐activated protein kinase kinase (MEK) inhibitors used to treat low‐grade gliomas and plexiform neurofibromas. Cutaneous toxicities are commonly associated with MEK inhibitors; however, limited studies have examined cutaneous effects in… read more here.
Keywords: binimetinib selumetinib; toxicities mek; cutaneous toxicities; mek inhibitors ... See more keywords